| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/25/2002 | WO2002056881A1 Fenofibrate tablets |
| 07/25/2002 | WO2002056879A1 Use of terpenes for the treatment of digestive tract infections |
| 07/25/2002 | WO2002056878A2 Pharmaceutical composition having reduced tendency for drug crystallization |
| 07/25/2002 | WO2002056877A1 Treatment of sleep disturbances |
| 07/25/2002 | WO2002056875A2 Method of treatment of dopamine-related dysfunction through administration of a full d1 dopamine receptor agonist and with no induction of tolerance |
| 07/25/2002 | WO2002056867A2 Extended release pharmaceutical compositions containing beta-lactam antibiotics |
| 07/25/2002 | WO2002056852A1 Cosmetics |
| 07/25/2002 | WO2002056843A2 Translucent nanoemulsion, production method, and uses thereof in the cosmetic, dermatological and/or ophthalmological fields |
| 07/25/2002 | WO2002056840A2 Cosmetic and/or pharmaceutical agent containing acylated amino acid |
| 07/25/2002 | WO2002056839A2 Pearlescent agent |
| 07/25/2002 | WO2002056833A2 Preparation of a therapeutic composition |
| 07/25/2002 | WO2002056831A2 Immunogenic proteoliposomes, and uses thereof |
| 07/25/2002 | WO2002056825A2 Composition and method to increase calcium levels in animals |
| 07/25/2002 | WO2002056808A1 Bioadhesive cell foam film of sustained-release delivery |
| 07/25/2002 | WO2002056790A2 Delivery of therapeutic capable agents |
| 07/25/2002 | WO2002056709A1 Ingestible compositions containing an odoriferous oil |
| 07/25/2002 | WO2002045698A3 Silicone gel sheet for treatment of scar tissue |
| 07/25/2002 | WO2002045697A3 Composite material for counteracting edema |
| 07/25/2002 | WO2002043663A3 Tetrapartate prodrugs |
| 07/25/2002 | WO2002038077A3 L-histidine in ophthalmic solutions |
| 07/25/2002 | WO2002036591A3 Inhalative solution formulation containing a tiotropium salt |
| 07/25/2002 | WO2002032941A3 The function of a haptoglobin-haemoglobin receptor and the uses thereof |
| 07/25/2002 | WO2002024152A3 Oil in glycerin emulsion |
| 07/25/2002 | WO2002020466B1 Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents |
| 07/25/2002 | WO2002017918A3 Sustained release formulations for growth hormone secretagogues |
| 07/25/2002 | WO2002017888A3 Controlled and sustained release properties of polyelectrolyte multilayer capsules |
| 07/25/2002 | WO2002015886A3 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor |
| 07/25/2002 | WO2002015884A3 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor |
| 07/25/2002 | WO2002015851A3 Storage stable tretinoin and 4-hydroxy anisole containing topical composition |
| 07/25/2002 | WO2002005849A3 Transportation of nucleic acid substances |
| 07/25/2002 | WO2002002147A3 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 07/25/2002 | WO2001097872B1 Bioadhesive compositions and methods of preparation and use |
| 07/25/2002 | WO2001068079A3 Viscoelastics for use in middle ear surgery |
| 07/25/2002 | WO2001043698A9 Topical ointment |
| 07/25/2002 | WO2001032204A3 Nucleic acid vaccine compositions having a mammalian cd80/cd86 gene promoter driving antigen expression |
| 07/25/2002 | WO2001003723A9 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 07/25/2002 | WO2001000654A9 Purification and stabilization of peptide and proteins in pharmaceutical agents |
| 07/25/2002 | US20020099321 Fluid retention assembly for an iontophoretic delivery device and associated method for preparing the same |
| 07/25/2002 | US20020099187 Process for preparing solubilization adjuvants from fusel oils and saccharides |
| 07/25/2002 | US20020099180 Human FAP-alpha-specific antibodies |
| 07/25/2002 | US20020099164 Can be used in development of physiologically stable, non-leaking, non-immunogenic, efficacious and safe targetable drug delivery systems e.g., for delivery of anti-HIV or anticancer drugs |
| 07/25/2002 | US20020099133 Used in biotechnology and medicine |
| 07/25/2002 | US20020099097 Pharmaceutical solutions of modafinil compounds |
| 07/25/2002 | US20020099067 Pharmaceutical compositions for sparingly soluble therapeutic agents |
| 07/25/2002 | US20020099041 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 07/25/2002 | US20020099018 Dissolving an oligopeptide, such as Bombesin-Antagonist, Protirelin, Somatostatin and Cetrorelix, in acetic acid; transferring the solution to water, and lyophilizing; treating female infertility; gonad protection |
| 07/25/2002 | US20020099013 Active agent delivery systems and methods for protecting and administering active agents |
| 07/25/2002 | US20020099005 Mucin is present in a natural or modified form; includes delivery of DNA, RNA, PNA, polynucleotides and proteins into cells, tissues or organisms; gene therapy; customized therapeutics; vaccination; drug delivery |
| 07/25/2002 | US20020099001 Proteins attached to three or more polymer molecules (e.g., polyethylene glycol), providing resistance against proteolysis and allows uptake into the blood; especially modified G-CSF and consensus interferon. |
| 07/25/2002 | US20020098999 Compounds for sustained release of orally delivered drugs |
| 07/25/2002 | US20020098581 Carcinoma associated antigen (SK1) monoclonal antibodies against SK1, methods of producing these antibodies and use therefor |
| 07/25/2002 | US20020098579 Methods and compositions for poly-beta-1-4-N acetylglucosamine cell therapy system |
| 07/25/2002 | US20020098359 Method and apparatus for manufacture of magnetizable microparticles |
| 07/25/2002 | US20020098302 Hardshell gelatin capsule reducing the static electricity and enhancing the lubrication of film |
| 07/25/2002 | US20020098271 Method for preparing a gamma-unsaturated beta-lactone and use thereof as an aromatic and flavouring ingredient |
| 07/25/2002 | US20020098242 Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production |
| 07/25/2002 | US20020098240 Compositions comprising modafinil compounds |
| 07/25/2002 | US20020098237 Neurotoxin implant |
| 07/25/2002 | US20020098236 Transport vectors |
| 07/25/2002 | US20020098235 Comprises methacrylic acid-methyl methacrylate copolymer layers for drug delivery to gastrointestinal tract |
| 07/25/2002 | US20020098233 Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
| 07/25/2002 | US20020098231 Antisense nucleotides; drug delivery; anticancer agents; gene expression inhibition |
| 07/25/2002 | US20020098227 Process for manufacturing coated granules with masked taste and immediate release of the active principle |
| 07/25/2002 | US20020098223 Recombinant cells comprising retroviral vector |
| 07/25/2002 | US20020098206 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides |
| 07/25/2002 | US20020098204 Veterinary vaccines |
| 07/25/2002 | US20020098203 Immnunologically active substance embedded in microparticles consisting of starch with amylopectin content greater than 85%; non-crosslinked |
| 07/25/2002 | US20020098192 Polyalkylene oxide-modified single chain polypeptides |
| 07/25/2002 | US20020098191 Expression vector encoding a CD4-gamma2 chimeric heavy chain homodimer |
| 07/25/2002 | US20020098161 Therapeutic polyanhydride compounds for drug delivery |
| 07/25/2002 | US20020098159 Surfactants and organic and/or inorganic acids |
| 07/25/2002 | DE10102005A1 Lustrous concentrate useful as an additive to give stable cosmetic or pharmaceutical preparations contains a wax and a nonionic and/or amphoteric surfactant |
| 07/25/2002 | DE10101529A1 A solution of cyclosporin in neutral oil, preferably medium chain triglyceride, is useful as an immunosuppressive agent |
| 07/25/2002 | CA2447606A1 Ternary biomolecule/polymer/surface-based immobilization systems |
| 07/25/2002 | CA2435443A1 Method of enhancing delivery of a therapeutic nucleic acid |
| 07/25/2002 | CA2435305A1 Extended release pharmaceutical compositions containing beta-lactam antibiotics |
| 07/25/2002 | CA2435287A1 Nucleic acid delivery formulations |
| 07/25/2002 | CA2435069A1 Treatment solution for taking care of wounds and dressing material to be used together with said treatment solution |
| 07/25/2002 | CA2434743A1 Stabilized brivudine topical formulations containing metal oxide pigments |
| 07/25/2002 | CA2434736A1 Method of treatment of dopamine-related dysfunction through administration of a full d1 dopamine receptor agonist and with no induction of tolerance |
| 07/25/2002 | CA2434636A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
| 07/25/2002 | CA2434338A1 Pharmaceutical composition having reduced tendency for drug crystallization |
| 07/25/2002 | CA2434284A1 Dehydrating agent and method for dehydrating moist article using the agent and dehydrated article obtained by the method |
| 07/25/2002 | CA2433862A1 Molecular antigen array presenting amyloid beta |
| 07/25/2002 | CA2433316A1 Molecular antigen array |
| 07/25/2002 | CA2431212A1 Immunogenic proteoliposomes, and uses thereof |
| 07/24/2002 | EP1224940A1 Liquid interferon-beta formulations |
| 07/24/2002 | EP1224939A1 Interferon complex and medicinal use thereof |
| 07/24/2002 | EP1224938A1 Gugulipid for treating cognitive disorders, hyperglycaemia and skin disorders |
| 07/24/2002 | EP1224937A1 Stable preparations for treating bedsore, skin ulcer and wound |
| 07/24/2002 | EP1224929A2 Powder formulations containing melezitose as a diluent |
| 07/24/2002 | EP1224290A1 Disulfide conjugated cell toxins and methods of making and using them |
| 07/24/2002 | EP1224280A2 Design of high affinity rnase h recruiting oligonucleotide |
| 07/24/2002 | EP1224279A2 Microbe, microbial exopolysaccharide, and uses thereof |
| 07/24/2002 | EP1224188A2 A salt of morphine |
| 07/24/2002 | EP1223990A1 Formulations of hyaluronic acid for delivery of osteogenic proteins |
| 07/24/2002 | EP1223987A2 Method |
| 07/24/2002 | EP1223986A2 Hydrogels derived from chitosan and poly(ethylene glycol) |
| 07/24/2002 | EP1223985A2 Dialysis solution including polyglycol osmotic agent |
| 07/24/2002 | EP1223984A2 Compounds that associate on the intermolecular level and aggregate bodies that contain them |